Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers B > Headlines for Biodel, Inc. > News item |
Moab Partners reports 7.7% stake in Biodel
By E. Janene Geiss
Philadelphia, Jan. 23 - Moab Partners, LP reported an investment of 7.7% in Biodel, Inc. as of Dec. 18, 2008, according to an SC 13G filing with the Securities and Exchange Commission.
That represents a passive stake of 1,837,316 shares.
Biodel is a biopharmaceutical drug-delivery company based in Danbury, Conn.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.